Now in its 9th edition, World Drug Safety Americas 2017 is the global leading drug safety strategy-led event for pharma and biotech organisations.
Since its launch in 2008, this conference has stood out from the crowd. The event has always provided a unique forum for industry and partners to learn about the latest developments in drug safety and how they can tackle day-to-day critical challenges. We’ve kept this as our core concept ever since and tailored our program year after year to address exciting and emerging topics of highest relevance to the industry at that time. Going into 2017, drug safety is still an important topic as priorities change and the regulatory backdrop continues to evolve. Now is the time to improve patient safety strategies to exceed expectations. The event builds on the success to date, covering new technologies in drug safety and offering the most innovative and freshest case studies on drug safety projects.
2017 is set to be bigger and better than ever before. The meeting has a high proportion of pharma organisations year on year. We attract the biggest industry players from large, small and medium pharma / biotech organisations. We will have even more perspectives including regional specialists, technology partners, consultancies, CROs and global directors in attendance. World Drug Safety Americas 2017 is the meeting place of global pioneers who are shaping the pharmacovigilance industry. They’ll be creating, discussing and debating pragmatic solutions to industry challenges and exploring the future of drug safety.
Over 200 attendees were there in 2016 from the regulatory, biopharma, CRO, technology and consultancy community.
Join us and be part of the story...